0SKN Stock Overview

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. More details

0SKN fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	3/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 10.8% below our estimate of its fair value

Earnings are forecast to grow 17.82% per year

Earnings grew by 17.9% over the past year

Risk Analysis

High level of non-cash earnings

My Notes

Capture your thoughts, links and company narrative

SKAN Group AG Competitors

Ergomed

AIM:ERGO

UK£701.1m

hVIVO

AIM:HVO

UK£130.0m

C4X Discovery Holdings

AIM:C4XD

UK£30.3m

Genus

LSE:GNS

UK£1.0b

Price History & Performance

Summary of share price highs, lows and changes for SKAN Group
Historical stock prices
Current Share Price	CHF 76.20
52 Week High	CHF 86.40
52 Week Low	CHF 69.50
Beta	0.98
1 Month Change	5.39%
3 Month Change	-3.77%
1 Year Change	-1.60%
3 Year Change	-3.18%
5 Year Change	n/a
Change since IPO	-10.60%

Recent updates

Shareholder Returns

	0SKN	GB Life Sciences	GB Market
7D	1.7%	-2.8%	1.3%
1Y	-1.6%	-29.1%	4.3%

Return vs Industry: 0SKN exceeded the UK Life Sciences industry which returned -29.1% over the past year.

Return vs Market: 0SKN underperformed the UK Market which returned 4.3% over the past year.

Price Volatility

Is 0SKN's price volatile compared to industry and market?
0SKN volatility
0SKN Average Weekly Movement	3.7%
Life Sciences Industry Average Movement	7.8%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.5%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: 0SKN has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0SKN's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1968	1,419	GL Huber	skan.com/de/home/

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard.

SKAN Group AG Fundamentals Summary

How do SKAN Group's earnings and revenue compare to its market cap?
0SKN fundamental statistics
Market cap	CHF 1.71b
Earnings (TTM)	CHF 32.24m
Revenue (TTM)	CHF 344.01m

53.1x

P/E Ratio

5.0x

P/S Ratio

Is 0SKN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0SKN income statement (TTM)
Revenue	CHF 344.01m
Cost of Revenue	CHF 95.69m
Gross Profit	CHF 248.32m
Other Expenses	CHF 216.08m
Earnings	CHF 32.24m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 25, 2025

Earnings per share (EPS)	1.43
Gross Margin	72.18%
Net Profit Margin	9.37%
Debt/Equity Ratio	3.5%

How did 0SKN perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

24%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/03 09:58
End of Day Share Price	2024/12/30 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SKAN Group AG is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Volker Bosse	Baader Helvea Equity Research
Leonildo Delgado	Baader Helvea Equity Research
Samuel England	Berenberg